1 L or HIV-1 PTAP L domain was inserted in the viral matrix protein.

2 isition of a host-specific adaptation in the viral matrix protein.

3  force of arenaviral budding and acts as the viral matrix protein.

4 ame detectable, but antibodies against Ebola viral matrix protein 40 (not in the vaccine) were not de

5  RNA genome encodes seven proteins including viral matrix protein 40 (VP40), which is the most abunda

6 inished the ability of Nedd4 to ubiquitinate viral matrix proteins and led to a decrease in the relea

7 structural features commonly associated with viral matrix proteins and that VP24 may have a role in v

8 tase and integrase, decreased amounts of the viral matrix protein, and trace quantities of the viral

9 ther HA (H1, B), neuraminidase (N1, N2, NB), viral matrix proteins, and nucleoproteins were also capt

10 nto the ORF and the spliced mRNA encodes the viral matrix protein (CM1) (242 aa).

11  envelope fusogenicity, interaction with the viral matrix protein during assembly, viral infectivity,

12     The nucleocapsid then interacts with the viral matrix protein, leading to specific packaging of t

13 ontents then acidify, causing changes in the viral matrix protein (M1) that coats the inner monolayer

14 luenza A viruses have been attributed to the viral matrix protein (M1), and a number of studies have

15                                              Viral matrix proteins of several enveloped RNA viruses p

16          The Marburg virus VP40 protein is a viral matrix protein that spontaneously buds from cells.

17   VLPs rely on the natural properties of the viral matrix protein (VP) 40 to drive budding of filamen

18  in amino acid changes were identified, 1 in viral matrix protein VP40 and 3 in L, the RNA-dependent

19 oose coil can be condensed by binding of the viral matrix protein VP40 to the C terminus of the nucle